Gregory A. Firestone - Feb 21, 2025 Form 4 Insider Report for TELA Bio, Inc. (TELA)

Role
Chief Commercial Officer
Signature
/s/ Megan Smeykal, Attorney-in-fact
Stock symbol
TELA
Transactions as of
Feb 21, 2025
Transactions value $
-$5,304
Form type
4
Date filed
2/25/2025, 04:57 PM
Previous filing
Oct 24, 2024
Next filing
Apr 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELA Common Stock Award $0 +51.6K +90.09% $0.00 109K Feb 21, 2025 Direct F1
transaction TELA Common Stock Tax liability -$990 -364 -0.33% $2.72 109K Feb 21, 2025 Direct F2
transaction TELA Common Stock Tax liability -$3.68K -1.35K -1.25% $2.72 107K Feb 23, 2025 Direct F2
transaction TELA Common Stock Tax liability -$636 -240 -0.22% $2.65 107K Feb 24, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TELA Stock Option (Right to Buy) Award $0 +75.9K $0.00 75.9K Feb 21, 2025 Common Stock 75.9K $2.72 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units ("RSUs") will vest in four equal annual installments beginning on February 21, 2026, subject to the Reporting Person's continuous service through the applicable vesting dates.
F2 Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of RSUs.
F3 The option vests 25% on February 21, 2026, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.